See more : SpareBank 1 Telemark (SBTE.OL) Income Statement Analysis – Financial Results
Complete financial analysis of Thor Medical ASA (TRMED.OL) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Thor Medical ASA, a leading company in the Biotechnology industry within the Healthcare sector.
You may be interested
- BBMG Corporation (BBMPY) Income Statement Analysis – Financial Results
- Emera Incorporated (EMA-PH.TO) Income Statement Analysis – Financial Results
- Lojas Quero-Quero S.A. (LJQQ3.SA) Income Statement Analysis – Financial Results
- Hyundai Autoever Corporation (307950.KS) Income Statement Analysis – Financial Results
- PT Summarecon Agung Tbk (SMRA.JK) Income Statement Analysis – Financial Results
Thor Medical ASA (TRMED.OL)
About Thor Medical ASA
Thor Medical ASA produces and supplies alpha-particle emitters for cancer therapy in Norway. The company was founded in 2017 and is headquartered in Oslo, Norway.
| Metric | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit Ratio | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 945.00K | 0.00 | 317.98M | 318.58M |
| General & Administrative | 1.57M | 28.77M | 24.89M | 28.15M |
| Selling & Marketing | 1.56M | 0.00 | 0.00 | 0.00 |
| SG&A | 3.14M | 28.77M | 24.89M | 28.15M |
| Other Expenses | 3.08M | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 7.16M | 0.00 | 442.43M | 434.16M |
| Cost & Expenses | 7.16M | 0.00 | 442.43M | 434.16M |
| Interest Income | 2.02M | 0.00 | 1.14M | 1.61M |
| Interest Expense | 0.00 | 0.00 | 414.00K | 471.00K |
| Depreciation & Amortization | 331.00K | 11.20M | 11.37M | 14.90M |
| EBITDA | -6.83M | 11.20M | -428.35M | -400.80M |
| EBITDA Ratio | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | -7.16M | 0.00 | -442.43M | -434.16M |
| Operating Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | 1.60M | 0.00 | 2.30M | 18.00M |
| Income Before Tax | -5.56M | 0.00 | -440.14M | -416.16M |
| Income Before Tax Ratio | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 1.00K | 311.24M | 1.17M | 914.00K |
| Net Income | -26.56M | -311.24M | -441.30M | -417.08M |
| Net Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | -0.03 | -2.70 | -4.65 | -5.92 |
| EPS Diluted | -0.03 | -2.70 | -4.65 | -5.92 |
| Weighted Avg Shares Out | 174.79M | 115.13M | 94.82M | 70.48M |
| Weighted Avg Shares Out (Dil) | 174.79M | 115.13M | 94.82M | 70.48M |
No news found for: TRMED.OL
Source: https://incomestatements.info
Category: Stock Reports